{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:54:31Z","timestamp":1786121671192,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016359","name":"Zhongnan Hospital of Wuhan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300675"],"award-info":[{"award-number":["82300675"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["824B2088"],"award-info":[{"award-number":["824B2088"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32470757"],"award-info":[{"award-number":["32470757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.trecan.2026.07.002","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:30:57Z","timestamp":1785411057000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune cell metabolic reprogramming mediates ICI therapy resistance"],"prefix":"10.1016","author":[{"given":"Zhi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kequan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-3803","authenticated-orcid":false,"given":"Yufeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2026.07.002_bb0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-025-01734-x","article-title":"Immune checkpoint inhibitors for the treatment of solid tumors and lymphoma in the past 26 years (2000\u20132025)","volume":"18","author":"Huang","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0010","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41571-025-01061-7","article-title":"Treatment of NSCLC after chemoimmunotherapy \u2013 are we making headway?","volume":"22","author":"Reck","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.07.002_bb0020","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.07.002_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-025-02327-3","article-title":"Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion","volume":"11","author":"Wu","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.07.002_bb0030","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/s41590-024-01985-9","article-title":"Histone lactylation drives CD8(+) T cell metabolism and function","volume":"25","author":"Raychaudhuri","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41573-024-01098-w","article-title":"Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer","volume":"24","author":"Viel","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.trecan.2026.07.002_bb0040","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41590-024-01811-2","article-title":"MEF2C regulates NK cell effector functions through control of lipid metabolism","volume":"25","author":"Li","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0045","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.cmet.2025.04.008","article-title":"Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming","volume":"37","author":"Niu","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.trecan.2026.07.002_bb0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s43556-025-00300-8","article-title":"Dendritic cells: understanding ontogeny, subsets, functions, and their clinical applications","volume":"6","author":"Li","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.trecan.2026.07.002_bb0055","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.immuni.2022.04.017","article-title":"Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion","volume":"55","author":"Wang","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2026.07.002_bb0060","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1158\/2159-8290.CD-21-1658","article-title":"The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma","volume":"12","author":"Hao","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2026.07.002_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.07.002_bb0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s42255-022-00550-8","article-title":"Switching to the cyclic pentose phosphate pathway powers the oxidative burst in activated neutrophils","volume":"4","author":"Britt","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.trecan.2026.07.002_bb0075","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41590-023-01738-0","article-title":"Lithium carbonate revitalizes tumor-reactive CD8(+) T cells by shunting lactic acid into mitochondria","volume":"25","author":"Ma","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0080","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.tips.2023.08.009","article-title":"Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities","volume":"44","author":"Borde","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.trecan.2026.07.002_bb0085","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41568-023-00615-0","article-title":"Stem-like exhausted and memory CD8(+) T cells in cancer","volume":"23","author":"Gebhardt","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2026.07.002_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf9522","article-title":"Mitochondrial metabolic flexibility is critical for CD8(+) T cell antitumor immunity","volume":"9","author":"Chen","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.trecan.2026.07.002_bb0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","article-title":"Cellular metabolism regulates the differentiation and function of T-cell subsets","volume":"21","author":"Ma","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0100","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(25)00083-X","article-title":"Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial","volume":"26","author":"Lou","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0105","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41423-024-01134-0","article-title":"Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through \u03b1-ketoglutarate and mTORC1 signaling","volume":"21","author":"Cai","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-025-02326-4","article-title":"Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.07.002_bb0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-023-01473-x","article-title":"Tumor-associated myeloid cells in cancer immunotherapy","volume":"16","author":"Cheng","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0120","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1038\/s41467-023-41470-9","article-title":"Metabolic reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.07.002_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumour microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0130","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1016\/j.cell.2025.10.030","article-title":"Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy","volume":"188","author":"von Locquenghien","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.07.002_bb0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-025-02334-4","article-title":"Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications","volume":"11","author":"Wang","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.07.002_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.07.002_bb0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0150","article-title":"Slimming and reinvigorating tumor-associated dendritic cells with hierarchical lipid rewiring nanoparticles","volume":"35","author":"Xu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.trecan.2026.07.002_bb0155","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/s41590-023-01540-y","article-title":"Distinct metabolic requirements regulate B cell activation and germinal center responses","volume":"24","author":"Sharma","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.trecan.2024.07.009","article-title":"CD4+ T cells in antitumor immunity","volume":"10","author":"Montauti","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2026.07.002_bb0165","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s42255-023-00853-4","article-title":"Glycolytic neutrophils accrued in the spleen compromise anti-tumour T cell immunity in breast cancer","volume":"5","author":"Wang","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.trecan.2026.07.002_bb0170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.trecan.2025.03.008","article-title":"New insights into tryptophan metabolism in cancer","volume":"11","author":"Liu","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2026.07.002_bb0175","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41392-025-02242-7","article-title":"Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.07.002_bb0180","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.7150\/thno.104557","article-title":"Tumor-derived exosomes induce neutrophil infiltration and reprogramming to promote T-cell exhaustion in hepatocellular carcinoma","volume":"15","author":"Bi","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.trecan.2026.07.002_bb0185","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.07.002_bb0190","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.7150\/thno.105276","article-title":"Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: targets and therapeutic strategies","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.trecan.2026.07.002_bb0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2026.07.002_bb0200","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-025-02367-9","article-title":"Transforming acidic coiled-coil-containing protein 3-mediated lipid metabolism reprogramming impairs CD8(+) T-cell cytotoxicity in hepatocellular carcinoma","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.07.002_bb0205","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.immuni.2024.07.003","article-title":"The cytokine Meteorin-like inhibits anti-tumor CD8+ T cell responses by disrupting mitochondrial function","volume":"57","author":"Jackson","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2026.07.002_bb0210","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41423-025-01290-x","article-title":"Harnessing nutrient scarcity for enhanced CAR-T-cell potency and safety in solid tumors","volume":"22","author":"Manchon","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0215","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.cmet.2021.03.023","article-title":"Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment","volume":"33","author":"Poznanski","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.trecan.2026.07.002_bb0220","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41590-023-01462-9","article-title":"Tumors evade immune cytotoxicity by altering the surface topology of NK cells","volume":"24","author":"Zheng","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41568-025-00883-y","article-title":"Epigenetic regulation of T cell exhaustion in cancer","volume":"26","author":"Kang","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2026.07.002_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj3020","article-title":"Nutrient-driven histone code determines exhausted CD8(+) T cell fates","volume":"387","author":"Ma","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.trecan.2026.07.002_bb0235","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.cell.2024.02.022","article-title":"Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer","volume":"187","author":"Jia","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.07.002_bb0240","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","article-title":"Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.07.002_bb0245","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41568-025-00817-8","article-title":"Targeted protein degradation for cancer therapy","volume":"25","author":"Hinterndorfer","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2026.07.002_bb0250","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-025-09000-3","article-title":"STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity","volume":"643","author":"Zhou","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.07.002_bb0255","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41571-025-01000-6","article-title":"Enhancing immunotherapy with tumour-responsive nanomaterials","volume":"22","author":"Linderman","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0260","doi-asserted-by":"crossref","first-page":"21969","DOI":"10.1021\/acsnano.5c00012","article-title":"Enhanced cuproptosis via metabolic reprogramming using copper-delivering Co-N-C single-atom nanozyme","volume":"19","author":"Kim","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.trecan.2026.07.002_bb0265","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.1038\/s41467-024-53010-0","article-title":"Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.07.002_bb0270","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","article-title":"CAR-T therapy in solid tumors","volume":"43","author":"Du","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.07.002_bb0275","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12943-025-02386-8","article-title":"Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives","volume":"24","author":"Azeez","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.trecan.2026.07.002_bb0280","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1038\/s41467-025-62134-w","article-title":"Mogat1 drives metabolic adaptations to evade immune surveillance","volume":"16","author":"Wei","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.07.002_bb0285","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.cmet.2025.08.009","article-title":"HEBP2-governed glutamine competition between tumor and macrophages dictates immunotherapy efficacy in triple-negative breast cancer","volume":"37","author":"Xiao","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.trecan.2026.07.002_bb0290","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41586-022-04499-2","article-title":"Tryptophan depletion results in tryptophan-to-phenylalanine substitutants","volume":"603","author":"Pataskar","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.07.002_bb0295","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1158\/1078-0432.CCR-24-0499","article-title":"A phase Ib\/II randomized clinical trial of oleclumab with or without durvalumab plus chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma","volume":"30","author":"Coveler","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2026.07.002_bb0300","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006287","article-title":"Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignancies","volume":"11","author":"Lopez","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2026.07.002_bb0305","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1038\/s41467-024-50998-3","article-title":"Targeting fatty acid oxidation enhances response to HER2-targeted therapy","volume":"15","author":"Nandi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.07.002_bb0310","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt2117","article-title":"CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor","volume":"11","author":"Sarkar","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.trecan.2026.07.002_bb0315","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/s41556-025-01815-6","article-title":"WDR4 drives tumour-associated macrophage reprogramming and tumour progression via selective translation and membrane cholesterol efflux","volume":"27","author":"Liu","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0320","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/s41467-024-47096-9","article-title":"Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies","volume":"15","author":"Daneshmandi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.07.002_bb0325","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.cmet.2025.03.003","article-title":"Pyruvate kinase M2 activation reprograms mitochondria in CD8 T cells, enhancing effector functions and efficacy of anti-PD1 therapy","volume":"37","author":"Mortazavi Farsani","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.trecan.2026.07.002_bb0330","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.immuni.2025.07.017","article-title":"Succinate preserves CD8+ T cell fitness to augment antitumor immunity","volume":"58","author":"Ma","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.trecan.2026.07.002_bb0335","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41590-024-02027-0","article-title":"Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1+CD8+ T cells","volume":"26","author":"Zhang","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2026.07.002_bb0340","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn1849","article-title":"Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments","volume":"10","author":"Kennedy","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.trecan.2026.07.002_bb0345","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tem.2024.08.009","article-title":"Metabolic reprogramming of macrophages in cancer therapy","volume":"36","author":"Wang","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.trecan.2026.07.002_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118188","article-title":"Co-targeting the CD73-adenosinergic axis enhances the anti-tumor efficacy of anti-PD-L1 immunotherapy in bladder cancer","volume":"188","author":"Furriel","year":"2025","journal-title":"Biomed. Pharmacother."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T05:57:50Z","timestamp":1786082270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803326001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":70,"alternative-id":["S2405803326001585"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2026.07.002","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune cell metabolic reprogramming mediates ICI therapy resistance","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2026.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}